Trastuzumab in advanced breast cancer – a decade of experience in Germany

BACKGROUND: Trastuzumab was registered in 2000 for the treatment of metastatic breast cancer, both as monotherapy and combination therapy with paclitaxel. In this prospective, non-interventional observation study, the 10-year experience with trastuzumab in the routine management of HER2-positive bre...

Descripción completa

Detalles Bibliográficos
Autores principales: Jackisch, Christian, Schoenegg, Winfried, Reichert, Dietmar, Welslau, Manfred, Selbach, Johannes, Harich, Hanns-Detlev, Tesch, Hans, Wohlfarth, Tim, Eustermann, Heidi, Hinke, Axel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4295514/
https://www.ncbi.nlm.nih.gov/pubmed/25487774
http://dx.doi.org/10.1186/1471-2407-14-924

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4295514/
https://www.ncbi.nlm.nih.gov/pubmed/25487774
http://dx.doi.org/10.1186/1471-2407-14-924

Ejemplares similares